AI-enabled symptom checker Infermedica announced a 3.65 million dollar funding round. COBALT advised Karma Ventures who lead the round with participation from Dreamit Ventures, Inovo Venture Partners and Müller Medien.
Karma Ventures is an early-stage venture capital firm, specialised in late seed and A round investments in Europe’s most promising tech startups. COBALT has previously advised Karma Ventures on investments in Realeyes, AppGyver, Plumbr, Adaptive Simulations, Minut, SpectX, Sonarworks, CGTrader and MeetFrank.
The client was advised by partner Kristel Raidla-Talur, senior associate Greete-Kristiine Kuru and associate Sven Böttcher.
More information can be found here.